Early Radiation Toxicity from Yttrium-90 Radioembolization for Advanced Hepatocellular Carcinoma

Am J Respir Crit Care Med. 2016 Apr 1;193(7):804-5. doi: 10.1164/rccm.201508-1550IM.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Hepatocellular / complications
  • Carcinoma, Hepatocellular / therapy*
  • Comorbidity
  • Dyspnea / drug therapy*
  • Dyspnea / etiology
  • Embolization, Therapeutic / adverse effects
  • Embolization, Therapeutic / methods
  • Hepatitis B virus
  • Humans
  • Liver Cirrhosis / virology*
  • Liver Neoplasms / complications
  • Liver Neoplasms / therapy*
  • Lung Injury / etiology*
  • Male
  • Middle Aged
  • Niacinamide / analogs & derivatives
  • Niacinamide / therapeutic use
  • Phenylurea Compounds / therapeutic use
  • Prednisone / administration & dosage
  • Prednisone / therapeutic use*
  • Radiation Exposure / adverse effects*
  • Sorafenib
  • Ytterbium / adverse effects
  • Ytterbium / therapeutic use*

Substances

  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Phenylurea Compounds
  • Niacinamide
  • Sorafenib
  • Ytterbium
  • Prednisone